Launch preparation for an imaging agent for cancer diagnosis
The challenge
Supporting our client across a range of research activities, including:
Positioning the product in Europe and US
Identifying post-launch barriers to uptake
Name testing ahead of US launch
Assessing opportunity for expansion into new clinical settings (EU and US)
The approach
Qualitative projects, including projective techniques to identify and understand different customer segments
Quantitative projects including trade-off exercises
Purdie Pascoe value added
Strong therapy knowledge
Qualitative and quantitative capabilities
Good working relationship with senior stakeholders, allowing consultative/partnership approach to planning MR approach and strategy
Business Impact
“Purdie Pascoe were responsive, understood the category and were able to supply global and US insights in a timely manner.
They were able to help work within tight timelines and budgets while providing high quality work.
I have come to regard them as an objective and responsive part of our team.”
Director, Urology
